Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Lnc-PSMA8-1 activated by GEFT promotes rhabdomyosarcoma progression via upregulation of mTOR expression by sponging miR-144-3p

Fig. 2

Effects of lnc-CEACAM19-1, lnc-VWCE-2, lnc-GPX7-1, lnc-PSMA8-1, and lnc-FAM59A-1 on the proliferation and apoptosis of RMS cells. A: Effects on RD and RH30 cells transfected with siRNA (lnc-CEACAM19-1, lnc-VWCE-2, lnc-GPX7-1, or lnc-PSMA8-1) or lnc-FAM59A-1 overexpressed plasmid as detected by qRT-PCR. B: Proliferative capabilities of RD and RH30 cells transfected with siRNA (lnc-CEACAM19-1, lnc-VWCE-2, lnc-GPX7-1, or lnc-PSMA8-1) or lnc-FAM59A-1 overexpressed plasmid as determined through CCK-8 cell proliferation assay. C: Apoptosis rates of RD and RH30 cells transfected with siRNA (lnc-CEACAM19-1, lnc-VWCE-2, lnc-GPX7-1, or lnc-PSMA8-1) or lnc-FAM59A-1 overexpressed plasmid as determined through flow cytometry assay

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us